NCT04760613View on ClinicalTrials.gov

CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

June 7, 2023

Study Completion Date

June 7, 2023

Conditions
Radiculopathy
Interventions
DRUG

Cannabidiol

600 mg oral daily use (each capsule of active drug contains 50 mg of CBD)

DRUG

Placebo

identical capsules containing placebo (taken daily by mouth)

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

NYU Langone Health

OTHER